semaglutide دواء (Rybelsus): The only oral #GLP1 analogue Available in 3-mg,7-mg,14-mg tablet per @Saudi_FDA and the prices are listed: #diabetes #endocrine #CardioTwitter #endotwitter Novo Nordisk medicines containing semaglutide

PlexusDx explains the clinical approach to semaglutide initiation and how personalized dosing strategies support your weight loss goals

The next leap forward in healthcare will emerge from the integration of scientific discovery with the systems designed to make it accessible, safe, and enduring

The GLP-1RA group had greater weight loss during the weight maintenance period (2.3kg (95% CI=0.6 to 4.0)), and had fewer meal replacements per day compared with the control group (minus one meal per day (95% CI=0.6 to 1)), P<0.001

Carmot acquisition propels Roche to forefront of obesity drug leadership, finds GlobalData In a significant move in December 2023, Roche completed the acquisition of the US-based company Carmot Therapeutics in a deal worth $2.9 billion

Conclusions Consistent with clinical trials, real-world tirzepatide treatment was associated with greater 6-month weight reduction and more frequent achievement of weight-reduction targets and improvements in select cardiometabolic parameters than semaglutide among adults with obesity without diabetes

Using a global dataset and propensity matching, they found significantly lower mortality rates, major cardiovascular events (MACEs), and adverse kidney outcomes (MAKEs) among GLP-1 RA users compared to non-users